(((2R,3R,4S)-2-(((tert-Butyldimethylsilyl)oxy)methyl)-3,4-dihydro-2H-pyran-3,4-diyl)bis(oxy))bis(tert-butyldimethylsilane)

Catalog No. :
ACOGTJ228
CAS No. :
128822-21-9
Molecular Formula :
C24H52O4Si3
Molecular Weight :
488.93

IUPAC Name:(((2R,3R,4S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-3,4-dihydro-2H-pyran-3,4-diyl)bis(oxy))bis(tert-butyldimethylsilane)

(((2R,3R,4S)-2-(((tert-Butyldimethylsilyl)oxy)methyl)-3,4-dihydro-2H-pyran-3,4-diyl)bis(oxy))bis(tert-butyldimethylsilane) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$65.00Login to see priceInquiryInquiry
5g97%$217.00Login to see priceInquiryInquiry
25g97%$543.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(((2R,3R,4S)-2-(((tert-Butyldimethylsilyl)oxy)methyl)-3,4-dihydro-2H-pyran-3,4-diyl)bis(oxy))bis(tert-butyldimethylsilane)
IUPAC Name(((2R,3R,4S)-2-(((tert-butyldimethylsilyl)oxy)methyl)-3,4-dihydro-2H-pyran-3,4-diyl)bis(oxy))bis(tert-butyldimethylsilane)
Molecular FormulaC24H52O4Si3
Molecular Weight488.93
SMILESC[Si](OC[C@@H]1[C@@H](O[Si](C)(C(C)(C)C)C)[C@@H](O[Si](C)(C(C)(C)C)C)C=CO1)(C(C)(C)C)C
InChI KeyFMXIGEXRLSNRMR-HBMCJLEFSA-N
SynonymD-ribo-Hex-1-enitol, 1,5-anhydro-2-deoxy-3,4,6-tris-O-[(1,1-dimethylethyl)dimethylsilyl]-;tri-O-(tert-butyldimethylsilyl)allal
CAS No.128822-21-9

Synthetic Route by SureRoute

1. ACOGTJ228 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOGTJ228 route product structure diagram
    ACOGTJ228128822-21-9
Inquiry

2. ACOGTJ228 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOGTJ228 route product structure diagram
    ACOGTJ228128822-21-9
Inquiry

Comments (0)